SEC Form 4 · accession 0000899243-16-023280
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
HedgePath, LLC
10% Owner
Period of report
Jun 15, 2016
Accepted (ET)
Jun 20, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value per shareF1 | Jun 15, 2016 | S$0 | 2,560,000 | — | D | 82,127,069 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 15, 2016, the Reporting Person transferred 2,560,000 shares of common stock in a private transaction to a third party in satisfaction of $192,000 in then outstanding debt.